Should Testosterone Replacement Therapy (TRT) be less regulated?

Should Testosterone Replacement Therapy (TRT) be less regulated? This US debate has significant implications for India.

For our pharma industry, easier access could unlock a massive market, but also amplify concerns around responsible prescribing and potential misuse. How do we ensure genuine medical need drives demand, not just lifestyle choices? A critical regulatory discussion awaits.

https://medcitynews.com/2026/02/medcity-pivot-podcast-should-testosterone-replacement-therapy-be-less-regulated/